CINECA IRIS Institutional Research Information System

BENVENUTI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.720
AS - Asia 1.140
EU - Europa 1.100
SA - Sud America 174
AF - Africa 75
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.656
IT - Italia 525
SG - Singapore 386
CN - Cina 335
HK - Hong Kong 173
BR - Brasile 149
DE - Germania 103
SE - Svezia 98
FI - Finlandia 71
VN - Vietnam 61
AT - Austria 55
GB - Regno Unito 52
BG - Bulgaria 46
FR - Francia 39
KR - Corea 36
CA - Canada 30
RU - Federazione Russa 29
CI - Costa d'Avorio 25
JP - Giappone 24
NL - Olanda 24
IN - India 23
IR - Iran 22
MX - Messico 21
SN - Senegal 19
PL - Polonia 18
AR - Argentina 17
TR - Turchia 13
BD - Bangladesh 9
IQ - Iraq 8
PK - Pakistan 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
LT - Lituania 6
NG - Nigeria 6
MA - Marocco 5
MY - Malesia 5
UA - Ucraina 5
ES - Italia 4
ID - Indonesia 4
IE - Irlanda 4
JM - Giamaica 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
EG - Egitto 3
GH - Ghana 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CH - Svizzera 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
TH - Thailandia 2
UG - Uganda 2
AL - Albania 1
AU - Australia 1
BS - Bahamas 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.212
Salva come PNG Salva come JPEG
Città #
Ashburn 258
Dallas 244
Singapore 193
Hong Kong 167
Santa Clara 130
Chandler 105
Fairfield 101
Milan 80
Shanghai 71
Pisa 70
Los Angeles 57
Boardman 56
Hefei 56
New York 53
Houston 52
Wilmington 50
Seattle 49
Beijing 46
Munich 46
Sofia 44
Vienna 42
Woodbridge 41
Cambridge 36
Florence 35
Lucca 35
Seoul 35
Serra 35
London 34
Lappeenranta 33
Rome 29
Abidjan 25
Turku 22
Princeton 21
Chicago 20
Frankfurt am Main 20
Bremen 19
Dakar 19
Ho Chi Minh City 18
Lawrence 16
Livorno 16
Tokyo 16
Helsinki 15
Medford 15
Warsaw 14
Dong Ket 13
Montignoso 13
São Paulo 13
Atlanta 10
Buffalo 10
Ottawa 10
Redondo Beach 10
Des Moines 9
Istanbul 9
Marseille 9
Montreal 9
Naples 9
Nuremberg 9
Ogden 9
Kent 8
Phoenix 8
Aguascalientes 7
Ann Arbor 7
Brno 7
Chennai 7
San Giuliano Terme 7
Tashkent 7
Brooklyn 6
Hanoi 6
Lagos 6
Pistoia 6
Toronto 6
Wuhan 6
Xi'an 6
Amsterdam 5
Columbus 5
Fuzhou 5
Nanjing 5
Brescia 4
Campinas 4
Cascina 4
Denver 4
Dublin 4
Fragagnano 4
Groningen 4
Guangzhou 4
Johannesburg 4
Kuala Lumpur 4
Mexico City 4
Poplar 4
Rio de Janeiro 4
Rostov-on-Don 4
Shenzhen 4
Zhengzhou 4
Americana 3
Baghdad 3
Baku 3
Changsha 3
Council Bluffs 3
Duque de Caxias 3
Düsseldorf 3
Totale 2.886
Salva come PNG Salva come JPEG
Nome #
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 215
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 209
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 206
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 194
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 178
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 168
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 168
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 164
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 164
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 160
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 160
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 157
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 150
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 150
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 146
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 132
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 128
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy 124
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 121
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 117
Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy 107
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) 104
null 103
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease 100
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 97
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 94
The adenosine system at the crossroads of intestinal inflammation and neoplasia 89
Gut-directed therapy in Parkinson’s disease 84
Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure 84
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 70
Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice 60
Totale 4.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 11 6 12 27 33 9 35
2021/2022212 11 2 5 7 41 31 8 6 20 16 19 46
2022/2023514 39 66 38 34 63 55 4 47 106 19 34 9
2023/2024569 33 49 76 34 70 67 17 42 36 38 43 64
2024/20251.336 28 38 34 81 89 167 138 67 148 128 172 246
2025/20261.180 129 216 272 209 217 137 0 0 0 0 0 0
Totale 4.346